Article 21 Mar 2024 Surely You Must Be Kidding, PTO?!? "No, And Don't Call Me Shirley!" – The Seemingly Slapstick (But Yet Unfunny) World Of Recent Patent Term Extension Decisions (PART 3 . . . And PART 3½) United States IP
Article 07 Mar 2024 Surely You Must Be Kidding, PTO?!? "No, And Don't Call Me Shirley!" – The Seemingly Slapstick (But Yet Unfunny) World Of Recent Patent Term Extension Decisions (PART 1) United States IP
Article 06 Mar 2024 FDA Knows Its Own Strength—And It Includes Concentration United States Healthcare
Article 15 Feb 2024 HP&M Counsel John Claud Provides Testimony To House Subcommittee On FDA Foreign Inspections United States Healthcare
Article 01 Feb 2024 A Bold Goal: Reshoring 25% Of Small Molecule API To The U.S. In 5 Years – APIIC's Report To The White House United States Healthcare
Article 01 Nov 2023 To List Or Not To List; That Is The Question – The FTC Signals The Potential For Greater Scrutiny Of Patent Information Submissions To FDA United States Healthcare
Article 13 Mar 2017 When Does The Expiration Of Pediatric Exclusivity Allow ANDA (Or 505(b)(2) NDA) Approval? The Case Of Generic BENICAR United States Healthcare